Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1996 Jan 9;93(1):316–320. doi: 10.1073/pnas.93.1.316

Estrogens increase the expression of fibulin-1, an extracellular matrix protein secreted by human ovarian cancer cells.

G M Clinton 1, C Rougeot 1, J Derancourt 1, P Roger 1, A Defrenne 1, S Godyna 1, W S Argraves 1, H Rochefort 1
PMCID: PMC40229  PMID: 8552629

Abstract

Ovarian cancers have a high ability to invade the peritoneal cavity and some are stimulated by estrogens. In an attempt to understand the mode of action of estrogens on these cancer cells and to develop new markers, we have characterized estrogen-regulated proteins. This study was aimed at identifying a protein secreted by ovarian cancer cells whose level was increased by estradiol [Galtier-Dereure, F., Capony, F., Maudelonde, T. & Rochefort, H. (1992) J. Clin. Endocrinol. Metab. 75, 1497-1502]. By using microprotein sequencing, the 110-kDa protein was identified as fibulin-1, a protein of the extracellular matrix that binds to fibronectin, laminin, and nidogen. The amount of immunoprecipitated fibulin-1 secreted into the medium and present in the cell extract was increased up to 10-fold by estradiol in three estrogen-responsive ovarian cancer cell lines. By immunohistochemistry fibulin-1 was located in the stroma of several ovarian cancers and cysts. The findings highlight a potential role for fibulin-1 in the spread of ovarian cancer in the peritoneal cavity and/or in distal metastases.

Full text

PDF
316

Images in this article

317Fig. 1
on p.317
318Fig. 3
on p.318
318Fig. 4
on p.318
319Fig. 5
on p.319

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Argraves W. S., Dickerson K., Burgess W. H., Ruoslahti E. Fibulin, a novel protein that interacts with the fibronectin receptor beta subunit cytoplasmic domain. Cell. 1989 Aug 25;58(4):623–629. doi: 10.1016/0092-8674(89)90097-4. [DOI] [PubMed] [Google Scholar]
  2. Argraves W. S., Tran H., Burgess W. H., Dickerson K. Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure. J Cell Biol. 1990 Dec;111(6 Pt 2):3155–3164. doi: 10.1083/jcb.111.6.3155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Balbona K., Tran H., Godyna S., Ingham K. C., Strickland D. K., Argraves W. S. Fibulin binds to itself and to the carboxyl-terminal heparin-binding region of fibronectin. J Biol Chem. 1992 Oct 5;267(28):20120–20125. [PubMed] [Google Scholar]
  4. Chien C. H., Wang F. F., Hamilton T. C. Transcriptional activation of c-myc proto-oncogene by estrogen in human ovarian cancer cells. Mol Cell Endocrinol. 1994 Feb;99(1):11–19. doi: 10.1016/0303-7207(94)90140-6. [DOI] [PubMed] [Google Scholar]
  5. Dickson R. B., McManaway M. E., Lippman M. E. Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science. 1986 Jun 20;232(4757):1540–1543. doi: 10.1126/science.3715461. [DOI] [PubMed] [Google Scholar]
  6. Galtier-Dereure F., Capony F., Maudelonde T., Rochefort H. Estradiol stimulates cell growth and secretion of procathepsin D and a 120-kilodalton protein in the human ovarian cancer cell line BG-1. J Clin Endocrinol Metab. 1992 Dec;75(6):1497–1502. doi: 10.1210/jcem.75.6.1464654. [DOI] [PubMed] [Google Scholar]
  7. Geisinger K. R., Kute T. E., Pettenati M. J., Welander C. E., Dennard Y., Collins L. A., Berens M. E. Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors. Cancer. 1989 Jan 15;63(2):280–288. doi: 10.1002/1097-0142(19890115)63:2<280::aid-cncr2820630213>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  8. Granai C. O. Ovarian cancer--unrealistic expectations. N Engl J Med. 1992 Jul 16;327(3):197–200. doi: 10.1056/NEJM199207163270313. [DOI] [PubMed] [Google Scholar]
  9. Hall J. M., Lee M. K., Newman B., Morrow J. E., Anderson L. A., Huey B., King M. C. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 1990 Dec 21;250(4988):1684–1689. doi: 10.1126/science.2270482. [DOI] [PubMed] [Google Scholar]
  10. Hua W., Christianson T., Rougeot C., Rochefort H., Clinton G. M. SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens. J Steroid Biochem Mol Biol. 1995 Dec;55(3-4):279–289. doi: 10.1016/0960-0760(95)00187-5. [DOI] [PubMed] [Google Scholar]
  11. Korenberg J. R., Chen X. N., Tran H., Argraves W. S. Localization of the human gene for fibulin-1 (FBLN1) to chromosome band 22q13.3. Cytogenet Cell Genet. 1995;68(3-4):192–193. doi: 10.1159/000133911. [DOI] [PubMed] [Google Scholar]
  12. Langdon S. P., Hirst G. L., Miller E. P., Hawkins R. A., Tesdale A. L., Smyth J. F., Miller W. R. The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines. J Steroid Biochem Mol Biol. 1994 Aug;50(3-4):131–135. doi: 10.1016/0960-0760(94)90019-1. [DOI] [PubMed] [Google Scholar]
  13. Lin Y. Z., Clinton G. M. A soluble protein related to the HER-2 proto-oncogene product is released from human breast carcinoma cells. Oncogene. 1991 Apr;6(4):639–643. [PubMed] [Google Scholar]
  14. Lippman M., Bolan G., Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 1976 Dec;36(12):4595–4601. [PubMed] [Google Scholar]
  15. Pan T. C., Kluge M., Zhang R. Z., Mayer U., Timpl R., Chu M. L. Sequence of extracellular mouse protein BM-90/fibulin and its calcium-dependent binding to other basement-membrane ligands. Eur J Biochem. 1993 Aug 1;215(3):733–740. doi: 10.1111/j.1432-1033.1993.tb18086.x. [DOI] [PubMed] [Google Scholar]
  16. Pearson W. R., Lipman D. J. Improved tools for biological sequence comparison. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2444–2448. doi: 10.1073/pnas.85.8.2444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rao B. R., Slotman B. J. Endocrine factors in common epithelial ovarian cancer. Endocr Rev. 1991 Feb;12(1):14–26. doi: 10.1210/edrv-12-1-14. [DOI] [PubMed] [Google Scholar]
  18. Roark E. F., Keene D. R., Haudenschild C. C., Godyna S., Little C. D., Argraves W. S. The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study. J Histochem Cytochem. 1995 Apr;43(4):401–411. doi: 10.1177/43.4.7534784. [DOI] [PubMed] [Google Scholar]
  19. Rochefort H. Oestrogens, proteases and breast cancer. From cell lines to clinical applications. Eur J Cancer. 1994;30A(10):1583–1586. doi: 10.1016/0959-8049(94)00317-x. [DOI] [PubMed] [Google Scholar]
  20. Rodriguez C., Calle E. E., Coates R. J., Miracle-McMahill H. L., Thun M. J., Heath C. W., Jr Estrogen replacement therapy and fatal ovarian cancer. Am J Epidemiol. 1995 May 1;141(9):828–835. doi: 10.1093/oxfordjournals.aje.a117518. [DOI] [PubMed] [Google Scholar]
  21. Sheikh M. S., Shao Z. M., Chen J. C., Fontana J. A. Differential regulation of matrix Gla protein (MGP) gene expression by retinoic acid and estrogen in human breast carcinoma cells. Mol Cell Endocrinol. 1993 Apr;92(2):153–160. doi: 10.1016/0303-7207(93)90002-2. [DOI] [PubMed] [Google Scholar]
  22. Spence S. G., Argraves W. S., Walters L., Hungerford J. E., Little C. D. Fibulin is localized at sites of epithelial-mesenchymal transitions in the early avian embryo. Dev Biol. 1992 Jun;151(2):473–484. doi: 10.1016/0012-1606(92)90186-k. [DOI] [PubMed] [Google Scholar]
  23. Tran H., Tanaka A., Litvinovich S. V., Medved L. V., Haudenschild C. C., Argraves W. S. The interaction of fibulin-1 with fibrinogen. A potential role in hemostasis and thrombosis. J Biol Chem. 1995 Aug 18;270(33):19458–19464. doi: 10.1074/jbc.270.33.19458. [DOI] [PubMed] [Google Scholar]
  24. Westley B., Rochefort H. A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell. 1980 Jun;20(2):353–362. doi: 10.1016/0092-8674(80)90621-2. [DOI] [PubMed] [Google Scholar]
  25. Wolf C. R., Hayward I. P., Lawrie S. S., Buckton K., McIntyre M. A., Adams D. J., Lewis A. D., Scott A. R., Smyth J. F. Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. Int J Cancer. 1987 Jun 15;39(6):695–702. doi: 10.1002/ijc.2910390607. [DOI] [PubMed] [Google Scholar]
  26. Zhang H. Y., Kluge M., Timpl R., Chu M. L., Ekblom P. The extracellular matrix glycoproteins BM-90 and tenascin are expressed in the mesenchyme at sites of endothelial-mesenchymal conversion in the embryonic mouse heart. Differentiation. 1993 Mar;52(3):211–220. doi: 10.1111/j.1432-0436.1993.tb00633.x. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES